(Q33943467)

30 July 2017

title

Human ARF protein interacts with topoisomerase I and stimulates its activity (English)

1 reference

30 July 2017

Karayan L

1

1 reference

30 July 2017

Riou JF

2

1 reference

30 July 2017

Séité P

3

1 reference

30 July 2017

Migeon J

4

1 reference

30 July 2017

Cantereau A

5

1 reference

30 July 2017

Larsen CJ

6

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

30 July 2017

1 reference

30 July 2017

volume

20

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

836-848

1 reference

p14ARF links the tumour suppressors RB and p53.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Identification of a nucleolin binding site in human topoisomerase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Mitotic chromosome condensation in the rDNA requires TRF4 and DNA topoisomerase I in Saccharomyces cerevisiae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Heat stress induces hsc70/nuclear topoisomerase I complex formation in vivo: evidence for hsc70-mediated, ATP-independent reactivation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Human topoisomerase IIalpha and IIbeta interact with the C-terminal region of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

The human protein p19ARF is not detected in hemopoietic human cell lines that abundantly express the alternative beta transcript of the p16INK4a/MTS1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

E1A signaling to p53 involves the p19(ARF) tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14(ARF) tumor suppressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

A topoisomerase II-dependent G2 cycle checkpoint in mammalian cells/.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Modulation of DNA Topoisomerase I Activity byp53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

The cell cycle-coupled expression of topoisomerase IIalpha during S phase is regulated by mRNA stability and is disrupted by heat shock or ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Scl 70 autoantibodies from scleroderma patients recognize a 95 kDa protein identified as DNA topoisomerase I

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Interaction between human topoisomerase I and a novel RING finger/arginine-serine protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

DNA topoisomerase I in oncology: Dr Jekyll or Mr Hyde?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Identification of a cryptic nucleolar-localization signal in MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

DNA topoisomerase I is involved in both repression and activation of transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Simian virus 40 large T antigen binds to topoisomerase I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Tumor surveillance via the ARF-p53 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

The RNA-splicing factor PSF/p54 controls DNA-topoisomerase I activity by a direct interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

DNA topoisomerase I: customs officer at the border between DNA and RNA worlds?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

The establishment of two cell lines from the insectspodoptera frugiperda (lepidoptera; noctuidae)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Nucleolar Arf sequesters Mdm2 and activates p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Binding of wild-type p53 by topoisomerase II and overexpression of topoisomerase II in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Mutations in human ARF exon 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

p19ARF links the tumour suppressor p53 to Ras

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

7 January 2021

p16INK4A and p19ARF act in overlapping pathways in cellular immortalization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

7 January 2021

The INK4a/ARF tumor suppressor: one gene--two products--two pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

7 January 2021

Premitotic chromosome individualization in mammalian cells depends on topoisomerase II activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

7 January 2021

The p53 tumor suppressor stimulates the catalytic activity of human topoisomerase IIalpha by enhancing the rate of ATP hydrolysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

7 January 2021

Immunolocalization of human p14(ARF) to the granular component of the interphase nucleolus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

7 January 2021

Alterations in the catalytic activity of yeast DNA topoisomerase I result in cell cycle arrest and cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

7 January 2021

Mechanism of action of eukaryotic DNA topoisomerase I and drugs targeted to the enzyme

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

7 January 2021

The p16INK4a/CDKN2A tumor suppressor and its relatives.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204170

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204170

1 reference

Dimensions Publication ID

30 July 2017

1053253131

0 references

1 reference